CYP39A1 Polyclonal Antibody

CYP39A1 (cytochrome P450 family 39 subfamily A member 1) encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum protein is involved in the conversion of cholesterol to bile acids. Its substrates include the oxysterols 25-hydroxycholesterol, 27-hydroxycholesterol and 24-hydroxycholesterol. Alternate splicing results in multiple transcript variants.

The CYP39A1 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of CYP39A1 protein expression. This antibody has been meticulously developed using advanced techniques to ensure exceptional sensitivity and accuracy in various applications, including Western blotting, immunohistochemistry, and immunofluorescence.

With its polyclonal nature, this antibody exhibits a broad reactivity towards CYP39A1 across multiple species, making it an ideal choice for researchers working with diverse biological samples. Its exceptional affinity and specificity enable precise identification and quantification of CYP39A1 protein levels, facilitating comprehensive investigations into its functional roles and regulatory mechanisms.

The CYP39A1 Polyclonal Antibody is manufactured under stringent quality control measures, ensuring batch-to-batch consistency and reproducibility. It is supplied as a ready-to-use solution, eliminating the need for time-consuming and error-prone antibody preparation. Its optimized formulation guarantees optimal performance and minimal background noise, enabling accurate and reliable results.

In summary, the CYP39A1 Polyclonal Antibody is a valuable tool for researchers seeking to explore the intricate functions of CYP39A1 protein. Its exceptional sensitivity, broad reactivity, and reliable performance make it an indispensable asset in various experimental settings, ultimately contributing to advancements in the field of molecular biology and biomedical research.